AUM001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AUM001, covering 2024-07-09 to 2024-07-09. Get the full timeline:
Most recent: Clinical Trial Update: MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer [Phase 2]